|
시장보고서
상품코드
2053242
스마트 인슐린 펜 시장 : 적응증별, 접속 기능별, 판매 채널별, 지역별Smart Insulin Pen Market, By Indication, By Connectivity, By Distribution Channel, By Geography |
||||||
스마트 인슐린 펜 시장은 2026년에 6,080만 달러에 달하고, 2033년까지 1억 3,020만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 11.5%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 6,080만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 11.50% | 시장 규모 예측(2033년) : | 1억 3,020만 달러 |
스마트 인슐린 펜은 직관적인 스마트폰 앱을 탑재한 재사용 가능한 주사 펜으로, 당뇨병 환자가 인슐린 투여를 보다 효과적으로 관리할 수 있도록 돕는 제품입니다. 이 스마트 시스템은 투여량을 계산하고 추적하며, 유용한 알림, 경고 및 보고서를 제공합니다. 이 제품들은 현재의 인슐린 펜에 부착하는 형태이거나, 바이알이나 일회용 펜 대신 프리필드 카트리지를 사용하는 재사용 가능한 형태로 제공됩니다. 최초의 인슐린 펜은 바이알이나 주사기를 대체하기 위해 1980년대 후반에 도입되었습니다. 이를 통해 더 정확한 투여, 복약 순응도 향상, 그리고 주사 부위의 통증 완화가 가능해졌습니다. 이러한 기기가 발전함에 따라 디지털 디스플레이와 최근 인슐린 투여량 기록 기능이 추가되었습니다. 결국, 일회용 인슐린 펜으로도 투여량을 보다 정확하게 추적할 수 있도록 데이터 추적용 어댑터가 개발되었습니다. 그 후, 혈당 측정, 연속 혈당 모니터링, 투여 시기 알림, 알림 기능 등이 추가되었습니다. 미국 식품의약국(FDA)의 승인을 받은 최초의 재사용 가능한 스마트 인슐린 펜은 2017년에 출시되었습니다. 스마트 펜은 사용 편의성을 중시하여 설계되었습니다. 스마트폰에 앱을 다운로드하고 인슐린 펜과 페어링하면 바로 사용을 시작할 수 있습니다. 이 기기는 블루투스 연결을 통해 실시간 데이터를 앱으로 전송합니다.
시장 역학
세계 당뇨병 환자 수 증가, 주요 시장 참여자들의 인수합병(M&A)과 같은 성장 전략 채택, 새로운 인슐린 제품의 출시, 그리고 연구 개발 활동이 전 세계 스마트 인슐린 펜 시장의 성장을 주도하고 있습니다. 예를 들어, 2021년 8월 12일, 미국에 본사를 둔 의료 서비스 기업인 메드트로닉(Medtronic)은 미국 식품의약국(FDA)의 승인을 받은 스마트 인슐린 펜 시스템 'InPen' 및 통합형 당뇨병 관리 앱을 제조하는 마찬가지로 미국에 본사를 둔 의료기기 제조업체인 컴패니언 메디컬(Companion Medical)의 인수 계획을 발표했습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음 매개변수를 바탕으로 세계 스마트 인슐린 펜 시장의 주요 기업 프로파일을 작성했습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기종 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자는 세계의 스마트 인슐린 펜 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 스마트 인슐린 펜 시장 : 적응증별(2021-2033년)
제5장 세계의 스마트 인슐린 펜 시장 : 접속성별(2021-2033년)
제6장 세계의 스마트 인슐린 펜 시장 : 유통 채널별(2021-2033년)
제7장 세계의 스마트 인슐린 펜 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
KTH 26.06.17Smart Insulin Pen Market is estimated to be valued at USD 60.8 Mn in 2026 and is expected to reach USD 130.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 60.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.50% | 2033 Value Projection: | USD 130.2 Mn |
A smart insulin pen is a reusable injector pen with an intuitive smartphone app that can help people with diabetes better manage insulin delivery. This smart system calculates and tracks doses and provides helpful reminders, alerts, and reports. They can come in the form of an add-on to current insulin pen or a reusable form which uses prefilled cartridges instead of vials or disposable pens. The first insulin pen devices were introduced in the late 1980s as an alternative to vials and syringes. They allowed for more accurate dosing, better adherence, and less injection site pain. As these devices evolved, they gained digital displays and memory of the most recent insulin doses. Eventually, data tracking attachments were developed to help disposable insulin pens keep better track of doses. Glucose sensing, continuous glucose monitoring, dosage timing, reminders, and other advancements followed. The first U.S. Food and Drug Administration (FDA)-cleared reusable smart insulin pen was launched in 2017. Smart pens are designed to be simple to use. Once the app is downloaded to smartphone and paired it with insulin pen, it is ready to go. The device sends real-time data to the app via Bluetooth connection.
Market Dynamics
Increasing prevalence of diabetes worldwide, adoption of growth strategies such as acquisitions and mergers from key market players, introduction of newer insulin products and research and development activities are driving the growth of global smart insulin pen market. For instance, in August 12, 2021, Medtronics, a U.S.-based medical service company, announced the planned acquisition of Companion Medical, a U.S.-based medical devices manufacturer, who is a manufacturer of InPen- a U.S. Food and Drug Administration cleared smart insulin pen system paired with an integrated diabetes management app.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global smart insulin pen market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Digital Medics Pty. Ltd., Emperra GmbH E-Health Technologies, Novo Nordisk, Companion Medical Inc., Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Pendiq GmbH, Sanofi, Berlin Chemie Companion Medical Inc., Bigfoot Biomedical, Digital Medics Pty ltd, Eli Lilly and company, Ypsomed Holding AG, Diabnext Diamesco Co. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global smart insulin pen market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smart insulin pen market.
Market Segmentation
- Global Smart Insulin Pen Market, By Indication (Revenue, USD Mn, 2021 - 2033)
- Type 1 Diabetes
- Type 2 Diabetes
- Global Smart Insulin Pen Market, By Connectivity (Revenue, USD Mn, 2021 - 2033)
- Bluetooth
- USB
- Global Smart Insulin Pen Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Clinics and Ambulatory Surgical Centers
- e-Commerce
- Retail Pharmacies
- Global Smart Insulin Pen Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Digital Medics Pty. Ltd.
- Emperra GmbH E-Health Technologies
- Novo Nordisk
- Companion Medical Inc.
- Jiangsu Deflu Medical Device Co. Ltd.
- Medtronic PLC
- Pendiq GmbH
- Sanofi
- Berlin Chemie Companion Medical Inc.
- Bigfoot Biomedical
- Digital Medics Pty Ltd.
- Eli Lilly and company
- Ypsomed Holding AG
- Diabnext Diamesco Co. Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Indication
- Market Snapshot, By Connectivity
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Smart Insulin Pen Market, By Indication, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Type 1 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Type 2 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Smart Insulin Pen Market, By Connectivity, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Bluetooth
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- USB
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Smart Insulin Pen Market, By Distribution Channel, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Clinics and Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- e-Commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Smart Insulin Pen Market, By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Digital Medics Pty. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Emperra GmbH E-Health Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novo Nordisk
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Companion Medical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Jiangsu Deflu Medical Device Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pendiq GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Berlin Chemie Companion Medical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bigfoot Biomedical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Digital Medics Pty Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ypsomed Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Diabnext Diamesco Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
